Overview
Zola Therapeutics is named for the first patient ever to receive what is now considered to be a cancer immunotherapy – in 1891. Zola is mimicking the replicative complexes of retroviruses to activate unparalleled anti-tumor immunity.
We do not yet have a logo or website, expect to share these when we come out of stealth around the end of 2024.